About Yacon
Yacon (Smallanthus sonchifolius) is an Andean tuber rich in fructooligosaccharides (FOS, 40-70% of dry weight) — the same inulin-type prebiotic fiber found in chicory and Jerusalem artichoke. The viral 'yacon syrup for weight loss' claim traces to a single small industry-funded RCT (Genta et al., 2009, Clinical Nutrition) in 55 obese pre-menopausal women with insulin resistance: 120 days of yacon syrup produced modest reductions in body weight (~15%), waist circumference, fasting insulin, HOMA-IR, and LDL. The trial has not been independently replicated at scale, and high dropout limits interpretation. Mechanism is plausible (FOS fermentation → SCFAs, Bifidobacterium proliferation, GLP-1/PYY elevation, increased satiety) but the clinical evidence base is one positive trial and a few small follow-ups. GI side effects (bloating, gas, cramping, diarrhea) are dose-limiting above ~20 g FOS/day; IBS/SIBO populations may not tolerate. Low caloric density (1.5-2 kcal/g vs sucrose's 4 kcal/g) makes yacon syrup a partial sugar substitute.
What Yacon supports
- Rich in prebiotic FOS (40-70% of dry weight) — fermented to SCFAs
- Supports Bifidobacterium and Lactobacillus populations
- Weight-loss claim rests on one small industry-funded trial (Genta 2009, n=55)
- Increased stool bulk and defecation frequency at supplemental doses
How much Yacon to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
300–1000
mg
Standardized root extract supplements typically 300-1000 mg/day. The pivotal Genta 2009 RCT used yacon SYRUP at ~0.14 g FOS/kg/day (~10 g FOS or 20-25 g syrup for a 70 kg adult) for 120 days. Higher doses (~0.29 g FOS/kg/day) trigger GI side effects. Capsule-form root extract has no clinically validated dose-response curve.
Clinical evidence
Limited clinical evidence. One small industry-funded RCT (Genta 2009, n=55 obese women, 120 days) showed body weight and insulin resistance improvements; not independently replicated at scale. Prebiotic FOS mechanism is mechanistically clear but clinical hard-outcome evidence is thin.
Examine.com